Biohaven Pharmaceutical Holding Co Ltd Earnings

The next earnings date for Biohaven Pharmaceutical Holding Co Ltd is May 8, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Biohaven Pharmaceutical Holding Co Ltd Earnings

Report Date	Estimated Earnings Per Share
05/08/2026	$-1.04

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Biohaven Pharmaceutical Holding Co Ltd Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
03/19/2026	---	$-0.90	23.73%
08/08/2025	---	$0	100.00%
08/04/2025	---	$0	100.00%
03/03/2025	---	$-1.71	-16.23%
11/13/2024	---	$-1.74	-12.21%
08/09/2024	---	$-3.50	-106.15%
05/09/2024	After Market	$-2.20	-40.13%
02/29/2024	After Market	$-1.81	-28.37%
11/14/2023	After Market	$-1.50	-11.94%
07/31/2023	Before Market	$-1.32	-9.09%
05/12/2023	After Market	$-1.03	26.95%
03/23/2023	After Market	$-3.32	-172.13%
11/09/2022	Before Market	$-1.75	25.21%
08/05/2022	Before Market	$-6.21	-140.70%
05/10/2022	Before Market	$-2.97	-17.39%
02/25/2022	Before Market	$-3.01	-47.55%
11/09/2021	Before Market	$-2.63	-9.58%
08/09/2021	Before Market	$-3.23	-18.75%
05/10/2021	Before Market	$-4.21	-49.29%
03/01/2021	Before Market	$-3.62	-21.89%
11/09/2020	Before Market	$-3.27	-13.15%
08/10/2020	Before Market	$-3.08	-18.01%
05/07/2020	After Market	$-3.07	-31.20%
02/25/2020	After Market	$-2.85	-52.41%
11/01/2019	After Market	$-2.04	-29.94%
08/08/2019	After Market	$-4.67	-143.23%
05/07/2019	Before Market	$-1.41	4.73%
02/28/2019	After Market	$-1.34	-10.74%
11/13/2018	After Market	$-1.53	-42.99%
08/14/2018	After Market	$-1.01	14.41%
05/15/2018	After Market	$-2.32	-103.51%
03/06/2018	After Market	$-0.75	37.50%
11/14/2017	After Market	$-1.19	-8.18%
08/14/2017	Before Market	$-1.78	-191.80%
06/15/2017	After Market	$-1.74	-120.25%
03/01/2017	---	$0	---
01/02/1991	---	$-4.67	---

More About Biohaven Pharmaceutical Holding Co Ltd

Website

https://www.biohaven.com

Country

USA

Full Time Employees

274

Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide. It develops BHV-1300, which is in Phase 2 clinical trial to treat Graves' disease and rheumatoid arthritis; BHV-1400 that is in Phase 2 clinical trial for treating IgA nephropathy; BHV-1600, which is in Phase 1 clinical trial for the treatment of peripartum cardiomyopathy; BHV-8000 that is in Phase 3 clinical trial for treating Parkinson's disease; Opakalim, which is in Phase 3 clinical trial for the treatment of focal epilepsy; BHV-2100 that is in Phase 2 clinical trial for the treatment of pain disorders; and BHV-2000, which is in Phase 2 clinical trial for treating obesity. The company is also developing BHV-1510 that is in Phase 2 clinical trial for the treatment of advanced or metastatic epithelial tumors; and BHV-1530, which is in Phase 2 clinical trial for treating urothelial cancer and other tumors. In addition, its preclinical product pipeline includes BHV-1310 for treating myasthenia gravis; BHV-1320 for treating immune mediated-diseases; BHV-1450 for treating Pemphigus, MuSK MG, and LGI-1 Encephalitis; BHV-1420 for treating membranous nephropathy; BHV-1440 for treating Graves' disease and TED; BHV-6500 for treating type 1 diabetes; BHV-1490 for treating IgM neuropathy and Waldenstrom's; BHV-8100 for treating neurodegenerative diseases; and BHV-1955 for treating tinnitus. The company was formerly known as Biohaven Research Ltd. and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut.

“Biohaven Pharmaceutical Holding Co Ltd Earnings” Can Refer to the Biohaven Pharmaceutical Holding Co Ltd Earnings Date

Some people say “Biohaven Pharmaceutical Holding Co Ltd earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Biohaven Pharmaceutical Holding Co Ltd position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Biohaven Pharmaceutical Holding Co Ltd Stock on the Earnings Date

If you own Biohaven Pharmaceutical Holding Co Ltd stock (BHVN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Biohaven Pharmaceutical Holding Co Ltd might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Biohaven Pharmaceutical Holding Co Ltd shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Biohaven Pharmaceutical Holding Co Ltd Earnings

You can contact us any time if you would like to ask questions about Biohaven Pharmaceutical Holding Co Ltd earnings or anything else related to the stock market.